Chemcrux Enterprises Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Chemcrux Enterprises Ltd is ₹ 77.72 as of 23 Mar 15:30 . The P/E Ratio of Chemcrux Enterprises Ltd changed from 15.3 on March 2022 to 0 on March 2021 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 0 on March 2021 . This represents a CAGR of -100.00% over 5 years The Market Cap of Chemcrux Enterprises Ltd changed from ₹ 226.58 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 5 years The revenue of Chemcrux Enterprises Ltd for the Dec '25 is ₹ 22.72 crore as compare to the Sep '25 revenue of ₹ 18.37 crore. This represent the growth of 23.68% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of Chemcrux Enterprises Ltd for the Dec '25 is ₹ 4.13 crore as compare to the Sep '25 ebitda of ₹ 2.42 crore. This represent the growth of 70.66% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of Chemcrux Enterprises Ltd changed from ₹ 1.24 crore to ₹ 1.58 crore over 7 quarters. This represents a CAGR of 14.85% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The Dividend Payout of Chemcrux Enterprises Ltd changed from 11.06 % on March 2021 to 35.35 % on March 2025 . This represents a CAGR of 26.16% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .

About Chemcrux Enterprises Ltd

Chemcrux Enterprises Limited was incorporated on April 15, 1996 with Registrar of Companies, Gujarat Dadra and Nagar Haveli.
The Company took over the business of M/s.
Chemcrux, a Partnership Firm in December, 1999, which was formed in 1981. Chemcrux Enterprises Limited is an ISO 9001:2008 and ISO 14001:2004 certified company and is engaged in High Pressure Oxidation, Chlorosulfonation, Nitration and Amidation Chemistry for manufacturing of intermediates for bulk drugs i.e.
APIs, dyes and pigments.
The Companys major selling products are Lassamide, various Chloro Benzoic Acids, and Nitro Benzoic Acids.

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

FAQs for the comparison of Chemcrux Enterprises Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, Chemcrux Enterprises Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of Chemcrux Enterprises Ltd is 116 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,637 Cr

What are the key factors driving the stock performance of Chemcrux Enterprises Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of Chemcrux Enterprises Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Chemcrux Enterprises Ltd and Tatva Chintan Pharma Chem Ltd?

As of March 23, 2026, the Chemcrux Enterprises Ltd stock price is INR ₹78.96. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1127.45.

How do dividend payouts of Chemcrux Enterprises Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of Chemcrux Enterprises Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.